Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter ended September 30, 2013.
“Teva’s leadership and Board of Directors remain committed to executing on our strategy and diligently implementing changes which we believe will ensure the growth of our business,” stated Eyal Desheh, Acting President and CEO of Teva.
Help employers find you! Check out all the jobs and post your resume.
